Bone marrow-derived cells and arterial disease

Jonathan Golledge1, Ann Van Campenhout, Shripad Pal

  • 1Vascular Biology Unit, School of Medicine, James Cook University, Townsville, Queensland, Australia. Jonathan.Golledge@jcu.edu.au

Journal of Vascular Surgery
|September 11, 2007
PubMed

Insights

Bone and artery diseases are linked, particularly through bone marrow progenitor cells. These cells show promise for vascular repair therapies, but further research is needed.

Area of Science:

  • Biomedical science
  • Vascular biology
  • Bone biology

Background:

  • Osteoporosis and atherosclerosis are frequently correlated.
  • Bone marrow progenitor cells play a role in the bone-artery connection.

Purpose of the Study:

  • To review the association between bone and artery diseases, focusing on progenitor cells.
  • To explore the role of bone marrow progenitor cells in vascular pathology.

Main Methods:

  • Literature review of previous publications.
  • Analysis of ongoing research by the authors.

Main Results:

  • Bone marrow progenitor cells, especially endothelial progenitor cells, are inversely correlated with atherosclerosis severity.
  • Therapeutic strategies targeting progenitor cells show potential for revascularization and vascular repair.
  • Specific progenitor cell subtypes may contribute to vascular pathology.

Conclusions:

  • Understanding the bone-artery pathophysiology link is crucial for developing novel vascular disease therapies.
  • Further investigation into bone marrow-derived progenitors is necessary to clarify their beneficial and pathological roles.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...